Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03509441 · ClinicalTrials.gov registry record
Early MRI Detection of Myocardial Deterioration as a Preventive, Disease Staging, and Prognostic Biomarker in Insulin Resistance
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 39
- Enrollment target
NCT03509441: Completed study, sponsored by Stanford University.
NCT03509441 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03509441 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the relationship between insulin resistance (IR) and myocardial tissue abnormalities. The study will focus on a patient population, South Asians, with a high prevalence of IR.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2015-01-15 |
| Est. Completion | 2019-11-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03509441
The ClinicalTrials.gov registry entry for NCT03509441 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03509441 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03509441 about?
NCT03509441 is a clinical study titled "Early MRI Detection of Myocardial Deterioration as a Preventive, Disease Staging, and Prognostic Biomarker in Insulin Resistance". The purpose of this study is to evaluate the relationship between insulin resistance (IR) and myocardial tissue abnormalities. The study will focus on a patient population, South Asians, with a high prevalence of IR.
What is the current status of trial NCT03509441?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2015-01-15. Estimated completion is 2019-11-11.
Who is sponsoring clinical trial NCT03509441?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.